Nom du produit:8-Bromo-1-methyl-6-(trifluoromethyl)quinoxaline-2,3(1H,4H)-dione

IUPAC Name:8-bromo-1-methyl-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione

CAS:1864016-15-8
Formule moléculaire:C10H6BrF3N2O2
Pureté:97%
Numéro de catalogue:CM221357
Poids moléculaire:323.07

Unité d'emballage Stock disponible Prix($) Quantité
CM221357-1g in stock șȋƻ
CM221357-5g in stock ƅƏƩ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1864016-15-8
Formule moléculaire:C10H6BrF3N2O2
Point de fusion:-
Code SMILES:O=C1N(C)C2=C(C=C(C(F)(F)F)C=C2Br)NC1=O
Densité:
Numéro de catalogue:CM221357
Poids moléculaire:323.07
Point d'ébullition:
N° Mdl:MFCD29035426
Stockage:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

Column Infos

Related Products